Connect with us

General News

Is Extracting Medical Cannabis Challenging?

Published

on

In the market, only a handful of companies are now integrating innovative technologies to extract medical cannabis. These technologies come up with high efficiency for operations at a smaller level that cannot develop the infrastructure themselves.

Medical cannabis extraction is of paramount importance in the whole process of medical cannabis production. The process can be challenging as engineers haven’t designed an equipment specifically for the cannabis extraction yet. Consequently, the yield is not at its optimum level.

Challenges for innovation in cannabis extraction

GMP (Good Manufacture Practices) certification is a standard to approve any industrial equipment and procedure. Currently, companies concerning the extraction have a tough time getting the GMP certification.

Some companies had applied for the certification for over a year but got no approval. However, different methods to extract medical cannabis are available which will not get a certification of GMP. Therefore, it is vital as a company to invest in the tools and devices that would be beneficial for the company.

The GMP will consider those techniques and equipment fit for approval that integrate the latest tech and depict specification.

Future of medical cannabis production

Medical cannabis products will be the deciding factor in the evolution of the extraction process. The carbon dioxide extraction method is among the popular methods to extract medical cannabis nowadays. It is because the extraction process does not need any bomb-proof amenities and is the method with no by-products.

Some companies are beginning to explore extraction methods of ethanol and hydrocarbon through butane and propane. Although these methods would need a bombproof material, the opportunity is considerable.

US and Canada realize that it can be challenging for organizations to develop a convenient infrastructure for extraction. Therefore, private medical cannabis extraction companies are advantageous for the emerging industry.

Europe, however, is deficient in creating innovative products. Mostly the products are dried cannabis or capsules. There is fundamentally no development in topical lotions, sublingual and transdermal products. It is something Europe will have to consider and learn from North America to get a good share in the global market.

What does the cannabis production market demand?

Medical cannabis will have the lion’s share in the contribution of cannabis market growth. The United States of America has had a fair deal of dedicated researchers and engineers for the matter. Canada is already joining hands with the US in the cause.

Anyhow, there are also high hopes from Europe in the market. With a population of 700 million people, the global medical cannabis market alone can make till around 200 billion USD.

After a decade or two, the shape of the global cannabis market will change entirely. Europe will also play a huge role in it along with North America and Israel.

However, research profiles are considerably low, and they need to speed up to better support the positive forecasts. The future of the market seems to be positive with the advent of more interest growing in the industry. However, there is a dire need to integrate the latest technologies that are solely specified for cannabis extraction.

 

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

General News

Dangerous Effects of Cannabis During Pregnancy Explained by New Research

Published

on

Cannabis is a derivative of Cannabis sativa that affects the normal functioning of the brain and impairs motor coordination leading to hallucinating effect. This new study suggests that cannabis exposure has real-time devastating effects on the fetus and placental development during the gestation period in pregnancy.

The principal constituent in cannabis is Tetrahydrocannabinol (THC) and the researchers at Western University and Queens University find that regular exposure to THC has a great effect on the development of the placenta and fetus during gestation. Since recreational cannabis has been legalized in Canada, the effects of cannabis during pregnancy are beginning to be perceived.

This study published in Nature’s Scientific Reports and it is available online.

Researchers used a rat model and human placental cells to show that regular exposure to THC during pregnancy has a great impact on not only the development of the vital organs of the fetus but also on the gene expression that is extremely important for the proper functioning of the placenta.

Read more- First Pneumonia Related Death Reported in China

The researchers practically find an 8 percent deduction in birth weight and diminished growth of brain and liver by more than 20 percent during gestation in a rat model due to the regular exposure to a low-dose of THC that copies the daily use of cannabis.

An associate professor, Daniel B. Hardy at Westerns Schulich School of Medicine and Dentistry and co-author on the paper suggests that the use of cannabis during pregnancy is highly linked with low birth weight babies.

Clinical data is hard to analyze because it is perplexed by other factors. The study is a definite way that supports that THC has a direct influence on the growth of the placenta and fetus.

Oxygen and nutrients cross the placenta into the developing fetus for nourishment and the research team characterizes how THC prevents oxygen and nutrients from crossing the placenta.

Read more- Global Alliance for Cannabis Commerce announces GACC Certified™ testing

A decrease in a glucose transporter called GLUT-1 is caused by the exposure to THC that was found by studying the placental cells of humans. This shows that THC is stopping the transfer of key nutrient glucose through the placenta, from mother to the fetus. A reduction in placental vasculature was also found in the rat model and infers a reduced flow of blood from the mother to the fetus.

In the researcher’s opinion the restricted growth they observed in the offspring is likely caused by both of these factors and find that there are recently no proper guidelines from Health Canada on the use of cannabis during the gestation period.

To prevent morning sickness, for anxiety, depression or social issues up to one in five women are using cannabis during pregnancy according to some studies.

A Ph.D.,  Associate Professor, David Natale at Queens finds in Canada and many states of the US the use of marijuana has been legalized, but its use during gestation period has not been studied well. There are very real devastating risks associated with the regular exposure of cannabis during pregnancy.

 

 

Continue Reading

General News

First Pneumonia Related Death Reported in China

Published

on

The first case of pneumonia-related death is reported this Saturday in China. It’s a 61 years old man who died with respiratory illness. This illness was caused by a new type of virus that belongs to the same family as that of SARS. Not to forget, SARS is the same virus that took hundreds of life some years ago.

Currently, forty-one people in Wuhan are diagnosed with this new pneumonia-like disease but it is not pneumonia. The experts believe it’s a new viral strain and a statement from the central Chinese city’s health commission on its official website has confirmed it.

After this first death, seven more cases are in critical condition. But two of them are discharged after recovering from the mysterious pneumonia-like disease. The emergence of this new virus has alarmed the health officials and scared the public due to the past SARS outbreak.

In 2002-2003, or Sudden Acute Respiratory Syndrome (SARS) topped the headlines with hundreds of people dying with it in China, Hongkong and many other parts of the world. Only in China SARS killed nearly 349 people and some 299 confirmed death cases in Hong Kong. It affected the national economy of these countries at large and completely distorted the tourism industry.

Read more- Global Alliance for Cannabis Commerce announces GACC Certified™ testing

Chinese scientists are investigating the root cause of this outbreak and they believe it’s a new strain from coronavirus. Coronavirus is a family of viruses that contain different mild and severe varieties of flu virus including common flu and SARS.

The researchers from Kong’s Department of Health in this death announcement on Saturday shared that genetic sequencing of this virus has been found in only one patient from the Wuhan region and is now available online. By going through its sequencing and comparing it with SARS shows that both of these viruses are 80% similar. However, it is too early to give a conclusion if it is SARS or something more deadly. They have warned the people and healthcare authorities to be vigilant this flu season.

Wong Ka-hin is the director at the department’s Health Protection Centre. He says that;

“We will remain alert as we believe the epidemic will continue to develop,”

Hong Kong authorities are trying to follow the necessary precautions to stop the spread of this new SARS-like virus. This includes disinfectant sprays in public transport i.e. trains and airplanes, checking of passengers and awareness campaigns on the new virus.

The Wuhan health commission further shares that this first person to die from the new viral disease bought eatables from a local seafood market. This seafood market was located in the city which is currently known to be the hub of this new flu outbreak in China and was cloves on January 1st for public safety.

The patient had the chronic liver disease but he died last Thursday due to “respiratory failure”. Ever since new cases are being detected nearly every day which shows that the evidence of this disease is contagious.

World health organization (WHO) said that there are no traveling restrictions necessary specific measures to follow during trade visits to China. It also expressed full confidence in Chinese health authorities to control the viral spread as soon as possible.

Continue Reading

General News

Global Alliance for Cannabis Commerce announces GACC Certified™ testing

Published

on

The Global Alliance for Cannabis Commerce (GACC) provides policymakers and legislators with the guidance necessary to take the nascent cannabis industry from the gray market into a global provider of medical and adult-use cannabis products.

Recently, the Company announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. The aim of this program is to provide licensed sellers and consumer confidence that the legal products are safe and they meet the purity standards. By the end of 2020, this program will be available to all state-licensed cannabis operations.

The Executive Director at GACC, Randal John Meyer says that with the current laws it is impossible to make sure that there are uniform standards for purity. Furthermore, GACC President Rezwan Khan added, ”GACC wants to establish a means by which consumers can have confidence in the products they buy and to provide the industry the tools to give this assurance.”

GACC and the member of the companies believe in establishing standards for safety and purity, and in creating a serious and effective testing program. Nominations for membership on the Standards Committee (terms are two years) will be open to the public beginning on Thursday, December 5, 2019, and closing on January 30, 2020.

The Board of GACC will determine the initial composition. Future members will include public nominations and will be determined by the GACCAST Standards Committee and reviewed by the GACC Board of Directors. It is expected that the GACCAST Standards Committee will take approximately nine months to establish the initial standards and protocols so that implementation can begin in 2020.

Brands such as Raw Garden, DNA Genetics, Crockett Family Farms, Urbn Leaf, La Familia, and Team Elite Genetics, and all derivative cannabis products from DNA Genetics’ and Crockett Family Farms’ genetic have pledged to support the development of the standards setting protocol and to adopt and implement it as well when it is effective.

To accommodate the entire legal cannabis industry’s access to this program, GACC will be creating a membership class, the Standard Membership, which involves minimal costs for participation, and that will provide access to the GACC Certified™ Program. GACC is also planning to arrange for testing discounts for members who use the GACC network of laboratories. The GACC President Rezwan Khan added, “Our goal is to ensure this program isn’t cost-prohibitive for any cannabis companies of any size.”

Solo sciences will be offering GACC members a substantial discount on anti-counterfeiting, instant product recall solo*CODE™ technology as they have previously partnered with GACC to ensure that medical patients and adult consumers do not unwittingly purchase counterfeit or illicit vape products.

On this account, the Executive Director of GACC added, “The combination of the voluntary GACC Certified™ consumer safety standard, particularly when combined with members’ access to substantially discounted solo*CODE™ anticounterfeiting technology, allows GACC members to provide their consumers with the confidence they need that anywhere in the United States they legally purchase a participating cannabis product, our blue leaf means it’s safe and genuine.”

Continue Reading

Trending